[논문]당뇨병성 망막병증에 대한 보양환오탕(補陽還五湯)의 효과: 체계적 문헌 고찰 및 메타분석

오정화; 김혜나; 윤화정

doi:10.6114/jkood.2023.36.4.051

[국내논문] 당뇨병성 망막병증에 대한 보양환오탕(補陽還五湯)의 효과: 체계적 문헌 고찰 및 메타분석
The Effect of Boyanghwano-tang for Diabetic Retinopathy: A Systematic Review and Meta-Analysis 원문보기

韓方眼耳鼻咽喉皮膚科學會誌 = The journal of Korean Medicine Ophthalmology & Otolaryngology & Dermatology, v.36 no.4, 2023년, pp.51 - 69

오정화 (동의대학교 한의과대학 안이비인후피부과학 교실) , 김혜나 (동의대학교 한의과대학 안이비인후피부과학 교실) , 윤화정 (동의대학교 한의과대학 안이비인후피부과학 교실)

Abstract ▼ AI-Helper

Objectives : The purpose of this study is to assess the effect of using Boyanghwano-tang(BYHWT) for diabetic retinopathy. Methods : We searched randomized controlled trials(RCTs) that used BYHWT for diabetic retinopathy in 10 databases(RISS, KISS, ScienceON, KCI, OASIS, DBpia, CNKI, Wanfang Database, PubMed, Cochrane Library) on August 12, 2023. Outcome measurements included total effective rate(TER) and visual acuity as the primary outcome measurements, and the secondary outcome measurements included fasting blood glucose(FBG), 2hPG, HbA1c, ET-1, NO, etc. The indicator of stability included adverse reactions. A meta-analysis was conducted according to TER, visual acuity, FBG. Results : A total of 8 randomized control trials were selected. The treatment group which used BYHWT showed significant improvement effects in TER and visual acuity compared to the control group which used western medicine or chinese patent medicine alone. TER: (RR: 1.22, CI 1.14 to 1.31, P=<0.00001), visual acuity: (RR: 2.06, CI 1.40 to 3.03, P=0.0002). Secondary outcome measurements including FBG also showed improvement in the treatment group compared to the control group. FBG: (MD: -0.15, CI -0.43 to 0.31, P=0.28). Adverse reactions were only mentioned in one study, which showed that no adverse reactions occurred in both the treatment and control groups. Conclusions : This study suggests that BYHWT is effective for diabetic retinopathy. However these findings should be interpreted cautiously due to the insufficient number of studies and unknown or high risk of bias in the included trials.

주제어

표/그림 (10)

그림 Fig. 1. PRISMA Flow Chart
표 Table 1. Summary of Included Studies
표 Table 2. Herbal Materials which Composed of Boyanghwano-tang Gagam
표 Table 3. Efficacy Evaluation
그림 Fig. 2. Forest Plot : Comparison of TER. BYHWT(ALL), BYHWT(ALL)+WM+CM VS WM+CM BYHWT : Boyanghwano-tang, BYHWT(ALL) : BYHWT, Modified BYHWT, BYHWT combined with other decotion, WM : Western medicine, CM : Chinese patent medicine
그림 Fig. 3. Forest Plot : Comparison of TER. BYHWT(ALL)+WM VS WM
그림 Fig. 4. Forest Plot : Comparison of Visucal Improvement. BYHWT+Modified BYHWT+WM+CM VS WM+CM
그림 Fig. 5. Forest Plot : Comparison of FBG. BYHWT+Modified BYHWT+WM VS WM
그림 Fig. 6. Risk of Bias Summary
그림 Fig. 7. Risk of Bias Graph

참고문헌 (31)

Kim HS, Kim HM, Seong GJ, Yoo YS, Kwak SI, Kim SJ, et al. Ophthalmology. 10th ed. Seoul:Ilchokak. 2014:268-73,279-83,430-2.？
Korea Disease Control and Prevention Agency. Health Statistics 2021. 2022[cited 2022 DEC 30]. Available from: https://knhanes.kdca.go.kr/knhanes/sub04/sub04_04_01.do.？
Korea Disease Control and Prevention Agency. Health Statistics 2012. 2013[cited 2013 DEC 24]. Available from: https://knhanes.kdca.go.kr/knhanes/sub04/sub04_04_01.do.？
Yoon JS, Baek SK, Lee YH. Risk Factor Analysis of Diabetic Retinopathy Diagnosed with Non-mydriatic Fundus Camera: KNHANES V. Journal of The Korean Ophthalmological Society. 2019;60(6):555-68.？
The Society of Korean Medicine Ophthalomology, Otolaryngology & Dermatology. Text of Traditional Korean Ophthalomology. 1st ed. Paju:Globooks. 2019:171,172.？
Hanuigwadaehak Bangjehak Pyeonchanwiwonhoe. Bangjehak. Seoul:Youngrimsa. 1999:414-6.？
Park JH, Han YH, Jun CY, Kim DU, Park SG, Lee CJH, et al. The Effects of Boyanghwanotang on the Thrombosis Related Factors. The Journal of Korean Oriental Internal Medicine. 2000;21(5):829-37.？
Jung WS, Ko CN, Kim YS, Bae HS, Lee KS. Experimental study on the effects of Boyanghwanoh-tang(補陽還五湯) on blood pressure and hyperlipidemia. The Journal of Korean Oriental Internal Medicine. 1997;18(2):246-67.？
Han CH, Pak YK. The Effect of Modified Boyanghwano-tang on the Brain Infarction Through the Anti-apoptosis of Neuronal Cells in Ischemic Rats. Journal of Korean acupuncture & moxibustion medicine society. 2010;27(4):29-38.？
Zhao J, Mo C, Meng LF, Liang CQ, Cao X, Shi W. Efficacy and safety of Buyang Huanwu Decoction for early-stage diabetic nephropathy: a Meta-analysis. Zhongguo Zhong Yao Za Zhi. 2019;44(8):1660-7.？
Zhang M, Hao X, Tang Y, Chen Y, He P, Zhao L, et al. Efficacy and safety of Buyang Huanwu decoction for diabetic peripheral neuropathy: a systematic review and Metaanalysis. The Journal of Traditional Chinese Medicine. 2023;43(5):841-50.？
Yao J, Weng H, Chen S. Clinical experience of Buyang Huanwu decoction combined with mosapride in the treatment of diabetic gastroparesis. Strait Pharmacy. 2020;32(11):167,168.？
Jung JH, Kwon K, Seo HS. Clinical Study on one Patient with Vitreous Hemorrhage Caused by Diabetic Retinopathy. J Korean Med Ophthalmol Otolaryngol Dermatol. 2004;17(2):112-9.？
Lee DJ, Lee ME, Kwon K, Seo HS. A Case Report of Diabetic Retinopathy Vitreous Hemorrhage. J Korean Med Ophthalmol Otolaryngol Dermatol. 2018;31(2):152-9.？
Zhong W, Du H. Curative Effect Analysis of Buyang Huanwu Decoction on Non-proliferative Diabetic Retinopathy. Smart Healthcare. 2019;30(5):173,174.？
Ai H. 40 cases of diabetic retinopathy treated with modified Buyang Huanwu Decoction and Liujunzi Decoction. Global Traditional Chinese Medicine. 2018;11(10):1614-7.？
Tang H, Song Y, Zhang Z, Wang Y. A review of the efficacy of Buyang Huanwu Decoction in the treatment of non-proliferative diabetic retinopathy. China Practical Medicine. 2013;8(8):172,173.？
Tang A, Li S, Hao X, Zhou W, Zhong J, Deng Y. Effect of modified Buyanghuanwu decoction on plasma ET - 1 and NO in nonproliferative diabetic retinopathy. Proceedings of the Fourteenth National Conference of Chinese Medicine on Diabete. 2011;28(12):2328,2329.？
Tang A, Li L, Zhou W. Influence of Buyanghuanwu decoction on hemorrheology in patients with nonproliferative diabetic retinopathy. Hebei Journal of Traditional Chinese Medicine. 2007;29(10):929-31.？
Lu Y. Clinical effects of combined laser and oriental medicine in the treatment of type 2 diabetic retinopathy. Inner Mongolia Journal of Traditional Chinese Medicine. 2020;39(3):125,126.？
Yang L. Clinical observation of Buyang Huanwu decoction combined with calcium dobesilate in treating diabetes retinopathy. CHINA'S NATUROPATHY. 2019;27(17):60,61.？
Qu L, Yao X. Observations on the integrated efficacy of Oriental medicine and Western medicine in the treatment of nonproliferative diabetic retinopathy. HENAN TRADITIONAL CHINESE MEDICINE. 2009;29(10):1019,1020.？
Zhang X, Liu W, Wu S, Jin J, Li W, Wang N. Calcium dobesilate for diabetic retinopathy: a systematic review and meta-analysis. Science China Life Sciences. 2015;58(1):101-7.？

상세보기
Jian W, Yu S, Tang M, Duan H, Huang J. A combination of the main constituents of Fufang Xueshuantong Capsules shows protective effects against streptozotocin-induced retinal lesions in rats. Journal of Ethnopharmacology. 2016;182:50-6.？

상세보기
Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Beket T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556-64.？

상세보기
Mansour SE, Browning DJ, Wong K, Flynn HW, Bhavsar AR. The Evolving Treatment of Di abetic Retinopathy. Clinical Ophthalmology. 2020;14:653-78.？

상세보기
Nuzzi R, Tridico F. Local and systemic compl ications after intravitreal administration of a nti-vascular endothelial growth factor agents in the treatment of different ocular diseases: a five-year retrospective study. Semin Ophth almol. 2015;30(2):129-35.？
Deschler EK, Sun JK, Silva PS. Side-effects and complications of laser treatment in diabetic retinal disease. Semin Ophthalmol. 2014;29(5):290-300.？
Korea Institute Of Oriental Medicine. MEDIC LASSICS. 2015[cited 2021 SEP 14]. Available from: https://mediclassics.kr/books/8/volume/14#content_1080？
Kai Z, Michela P, Antonio P, Annamaria P. Biological active ingredients of traditional Chinese herb Astragalus membranaceus on treatment of diabetes: a systematic review. Mini-Reviews in Medicinal Chemistry. 2015;15(4):315-29.？

상세보기
Jin Q, Hao XF, Xie LK, Xu J, Sun M, Yuan H, et al. A Network Pharmacology to Explore the Mechanism of Astragalus Membranaceus in the Treatment of Diabetic Retinopathy. Evidence-Based Complementary and Alternative Medicine. 2020;2020:1-12.

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증